Candida auris: From Multidrug Resistance to Pan-Resistant Strains

References

• Spivak ES, Hanson KE. Candida auris: an emerging fungal pathogen. J Clin Microbiol. 2018;56(2):1–10.
   Web of Science ®Google Scholar
• Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41–44. doi:10.1111/j.1348-0421.2008.00083.x19161556
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13:e1006290. doi:10.1371/journal.ppat.100629028542486
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Sharma C, Duggal S, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19(10):1670–1673.24048006
   PubMed Web of Science ®Google Scholar
• Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139–3142. doi:10.1128/JCM.00319-1121715586
   PubMed Web of Science ®Google Scholar
• Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(35):1–7. doi:10.1186/s13756-016-0132-526734130
   PubMed Web of Science ®Google Scholar
• Tsay S, Welsh RM, Adams EH, et al. Notes from the field: ongoing transmission of Candida auris in health care facilities- United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep. 2017;66:514–515. doi:10.15585/mmwr.mm6619a728520710
   PubMed Web of Science ®Google Scholar
• CDC. Candida auris: a drug-resistant germ that spreads in healthcare facilities. Available from: https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html. Accessed 115, 2020.
   Google Scholar
• Chowdhary A, Prakash A, Sharma C, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73:891–899. doi:10.1093/jac/dkx48029325167
   PubMed Web of Science ®Google Scholar
• Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6(69):1–13. doi:10.1186/s40560-018-0342-429308208
   PubMed Web of Science ®Google Scholar
• Sharma C, Kumar N, Pandey R, Meis JF, Chowdhary A. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes New Infect. 2016;13:77–82. doi:10.1016/j.nmni.2016.07.00327617098
   PubMedGoogle Scholar
• Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: not your grandfather’s Candida species. Clin Microbiol Newsl. 2017a;39:99–103. doi:10.1016/j.clinmicnews.2017.06.00329503491
   PubMedGoogle Scholar
• Sekyere JO. Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen. Microbiologyopen. 2018;7(4):1–29.
   Web of Science ®Google Scholar
• Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. Potential Fifth Clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019;25(9):1780–1781. doi:10.3201/eid2509.19068631310230
   PubMed Web of Science ®Google Scholar
• Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Armaki MT. Roodgari, et al. Candida auris otomycosis in Iran and review of recent literature. Mycoses. 2019;62:101–105.30585653
   PubMed Web of Science ®Google Scholar
• Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis. 2018;18(12):1377–1384. doi:10.1016/S1473-3099(18)30597-830293877
   PubMed Web of Science ®Google Scholar
• Emara M, Ahmad S, Khan Z, et al. Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis. 2015;21:1091–1092. doi:10.3201/eid2106.15027025989098
   PubMed Web of Science ®Google Scholar
• Rudramurthy SM, Chakrabarti A, Paul RA, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017;72:1794–1801. doi:10.1093/jac/dkx03428333181
   PubMed Web of Science ®Google Scholar
• Ruiz-Gaitán A, Moret AM, Tasias-Pitarch M, Aleixandre-López AI, Martínez-Morel H, Calabuig E. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses. 2018;61(7):498–505. doi:10.1111/myc.1278129655180
   PubMed Web of Science ®Google Scholar
• Larkin E, Hager C, Chandra J, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017;61(5):1–13. doi:10.1128/AAC.02396-16
   Web of Science ®Google Scholar
• Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017b;64(2):134–140. doi:10.1093/cid/ciw69127988485
   PubMed Web of Science ®Google Scholar
• Forsberg K, Woodworth K, Walters M, et al. Brendan Jackson1, Tom Chiller Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2019;57:1–12. doi:10.1093/mmy/myy05430085270
   PubMed Web of Science ®Google Scholar
• Adams E, Quinn M, Tsay S, et al. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis. 2018;24(10):1816–1824. doi:10.3201/eid2410.18064930226155
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Berman J, Novikov A. Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis. 2017;23(1):195–203. doi:10.3201/eid2302.161486
   PubMed Web of Science ®Google Scholar
• Azar MM, Turbett SE, Fishman JA, Pierce VM. Donor-derived transmission of Candida auris during lung transplantation. Clin Infect Dis. 2017;65:1040–1042. doi:10.1093/cid/cix46028520901
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: “new kid on the block” in hospital-associated infections? J Hosp Infect. 2016;94:209–212. doi:10.1016/j.jhin.2016.08.00427634564
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Anil Kumar V, Sharma C, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014;33:919–926. doi:10.1007/s10096-013-2027-124357342
   PubMed Web of Science ®Google Scholar
• Kathuria S, Singh PK, Sharma C, et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol. 2015;53:1823–1830. doi:10.1128/JCM.00367-1525809970
   PubMed Web of Science ®Google Scholar
• Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere. 2016;1(4):1–8. doi:10.1128/mSphere.00189-16
   Web of Science ®Google Scholar
• Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31:1–18.
   Web of Science ®Google Scholar
• Wattal C, Oberoi JK, Goel N, Raveendran R, Khanna S. Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis. 2017;36:807–812. doi:10.1007/s10096-016-2864-927987046
   PubMed Web of Science ®Google Scholar
• Kim TH, Kweon OJ, Kim HR, Lee MK. Identification of uncommon Candida species using commercial identification system. J Microbiol Biotechnol. 2016;26:2206–2213. doi:10.4014/jmb.1609.0901227713213
   PubMed Web of Science ®Google Scholar
• CDC. Algorithm to identify Candida auris based on phenotypic laboratory method and initial species identification. Available from: https://www.cdc.gov/fungal/.../candidiasis/pdf/Testing-algorithm-by-Method-temp.pdf. Accessed 613, 2019.
   Google Scholar
• Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol. 2017;55:2445–2452. doi:10.1128/JCM.00630-1728539346
   PubMed Web of Science ®Google Scholar
• Kumar D, Banerjee T, Pratap CB, Tilak R. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries. 2015;9:435–437. doi:10.3855/jidc.458225881537
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1–50. doi:10.1093/cid/civ119426679628
   PubMed Web of Science ®Google Scholar
• Navalkele BD, Revankar S, Chandrasekar P. Candida auris: a worrisome, globally emerging pathogen. Expert Rev Anti Infect Ther. 2017;15:819–827. doi:10.1080/14787210.2017.136499228783385
   PubMed Web of Science ®Google Scholar
• Alfouzan W, Dhar R, Albarrag A, Al-Abdely H. The emerging pathogen Candida auris: a focus on the Middle-Eastern countries. J Infect Public Heal. 2019;12(4):451–459. doi:10.1016/j.jiph.2019.03.009
   PubMed Web of Science ®Google Scholar
• Ostrowsky B, Greenko J, Adams E, et al. Candida auris isolates resistant to three classes of antifungal medications-New York, 2019. A CDC report, Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6901a2.htm. Accessed 113, 2020.
   Google Scholar
• ECDC (The European Centre for Disease Prevention and Control). Rapid risk assessment: candida auris in healthcare settings – europe. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-candida-auris-healthcare-settings-europe. Accessed 19, 2020.
   Google Scholar
• Guarner J. Buruli ulcer. Review of a neglected skin mycobacterial disease. J Clin Microbiol. 2018;56(4):1–8.
   Web of Science ®Google Scholar
• Singhala T, Kumara A, Boradea P, Shaha S, Soman R. Successful treatment of C. auris shunt infection with intraventricular caspofungin. Med Mycol Case Rep. 2018;22:35–37. doi:10.1016/j.mmcr.2018.08.00530140604
   PubMed Web of Science ®Google Scholar
• Fakhim H, Vaezi A, Dannaoui E, et al. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses. 2018;61:377–382. doi:10.1111/myc.1275429460345
   PubMed Web of Science ®Google Scholar
• Biagi MJ, Wiederhold NP, Gibas C, et al. Development of high-level echinocandin resistance in a patient with recurrent Candida auris candidemia secondary to chronic candiduria. Open Forum Infect Dis. 2019;6:1–5. doi:10.1093/ofid/ofz262
   Web of Science ®Google Scholar
• Leach L, Zhu Y, Chaturvedi S. Development and validation of a real-time PCR assay for rapid detection of Candida auris from surveillance samples. J Clin Microbiol. 2018;56(2):1–7.
   Web of Science ®Google Scholar
• Morales-Lopez SE, Parra-Giraldo CM, Ceballos-Garzon A, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23:162–164. doi:10.3201/eid2301.16149727983941
   PubMed Web of Science ®Google Scholar
• Vallabhaneni S, Kallen A, Tsay S, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus—United States, May 2013-August 2016. Am J Transplant. 2016;17(1):296–299. doi:10.1111/ajt.14121
   Web of Science ®Google Scholar
• Sarma S, Kumar N, Sharma S, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90–91. doi:10.4103/0255-0857.10874623508441
   PubMed Web of Science ®Google Scholar
• Public Health Ontario (Ontario Agency for Health Protection and Promotion), Provincial Infectious Diseases Advisory Committee. Interim Guide for Infection Prevention and Control of Candida Auris. Toronto, ON: Queen’s Printer for Ontario; 2019:1–16.
   Google Scholar
• CDC. Antibiotic resistance threats report. Available from: www.cdc.gov/DrugResistance/Biggest-Threats.html. Accessed 81, 2019.
   Google Scholar
• Caceres DH, Forsberg K, Welsh RM, et al. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi. 2019;5(111):1–11. doi:10.3390/jof5040111
   Web of Science ®Google Scholar
• Shackleton J, Schelenz S, Rochon M, Hall A, Ryan L, Cervera-Jackson R. The impact of environmental decontamination in a Candida auris outbreak. J Hosp Infect. 2016;94(1):S88–9.
   Google Scholar
• Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses. 2017;60:758–763. doi:10.1111/myc.1269928872735
   PubMed Web of Science ®Google Scholar
• Cadnum JL, Shaikh AA, Piedrahita CT, et al. Effectiveness of disinfectants against Candida auris and other Candida species. Infect Control Hosp Epidemiol. 2017;38:1240–1243. doi:10.1017/ice.2017.16228793937
   PubMed Web of Science ®Google Scholar
• Lamoth F, Kontoyiannis DP. The Candida auris alert: facts and perspectives. J Infect Dis. 2018;217:516–520. doi:10.1093/infdis/jix59729390110
   PubMed Web of Science ®Google Scholar
• Escandón P, Chow NA, Caceres DH, et al. Molecular epidemiology of Candida auris in colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis. 2019;68:15–21. doi:10.1093/cid/ciy41129788045
   PubMed Web of Science ®Google Scholar
• Prakash A, Sharma C, Singh A, Kumar Singh P, Kumar A, Hagen F. Evidence of genotypic diversity among Candida auris Isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect. 2016;22(3):277.e1-277.e9. doi:10.1016/j.cmi.2015.10.022
   Web of Science ®Google Scholar
• Rhodes J, Abdolrasouli A, Farrer RA, et al. Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. Emerg Microbes Infect. 2018;7(43):1–12. doi:10.1038/s41426-017-0002-029323102
   PubMed Web of Science ®Google Scholar